Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 48 of 48 entries
View as:

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy

Phase: N/A Priority: Normal
NCT ID: NCT03405714 Org: User:
Start: 06/01/18 End: 11/04/20 Due: 11/04/21

A Study to Demonstrate the Bioequivalence of Lacosamide Tablets and Dry Syrup in Healthy Male Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02972125 Org: User:
Start: 11/30/16 End: 03/31/17 Due: 03/31/18

A Study to Investigate the Bioequivalence of Lacosamide Tablet (200mg) and Syrup (10mg/ml) in Healthy Chinese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03086382 Org: User:
Start: 02/27/17 End: 03/28/17 Due: 03/28/18

A Study to Investigate the Bioequivalence of Lacosamide 200mg Administered as Intravenous Solution and Oral Tablet in Healthy Chinese Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03204474 Org: User:
Start: 06/08/17 End: 07/28/17 Due: 07/28/18

A Study to Test the Pharmacodynamic, Pharmacokinetic, Safety, and Tolerability of Padsevonil in Healthy Study Participants Receiving Either Ethanol or Cannabidiol

Phase: N/A Priority: Normal
NCT ID: NCT04039919 Org: User:
Start: 07/17/19 End: 05/22/20 Due: 05/22/21

A Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis

Phase: N/A Priority: Normal
NCT ID: NCT02963506 Org: User:
Start: 10/31/16 End: 08/31/18 Due: 08/31/19

Study to Evaluate the Effect of Coadministered Erythromycin on the Pharmacokinetics and Safety of Padsevonil

Phase: N/A Priority: Normal
NCT ID: NCT03480243 Org: User:
Start: 03/27/18 End: 08/02/18 Due: 08/02/19

A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02879877 Org: User:
Start: 07/11/16 End: 01/31/18 Due: 01/31/19

A Study to Assess the Effectiveness of Certolizumab Pegol in Patients With Axial Spondyloarthritis in Daily Life

Phase: N/A Priority: Normal
NCT ID: NCT02354105 Org: User:
Start: 01/12/15 End: 03/09/18 Due: 03/09/19

A Pharmacokinetic Study of Padsevonil in Study Participants With Either Normal or Moderately Impaired Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT04136444 Org: User:
Start: 10/28/19 End: 05/22/20 Due: 05/22/21

A Study to Assess the Efficacy and Safety of Brivaracetam as Treatment for Increased Seizure Activity in an Epilepsy Monitoring Unit Setting

Phase: N/A Priority: Normal
NCT ID: NCT03021018 Org: User:
Start: 02/06/17 End: 04/27/18 Due: 04/27/19

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Phase: N/A Priority: Normal
NCT ID: NCT02326272 Org: User:
Start: 12/15/14 End: 09/12/18 Due: 09/12/19

A Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Phase: N/A Priority: Normal
NCT ID: NCT03861481 Org: User:
Start: 03/26/19 End: 03/31/21 Due: 03/31/22

A Study in Participants With Epilepsy, to Evaluate the Pharmacokinetics, Safety and Tolerability of Oxcarbazepine on Padsevonil

Phase: N/A Priority: Normal
NCT ID: NCT03695094 Org: User:
Start: 09/18/18 End: 05/30/19 Due: 05/30/20

A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02873767 Org: User:
Start: 08/31/16 End: 02/28/17 Due: 02/28/18

Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02647697 Org: User:
Start: 01/31/16 End: 02/29/16 Due: 02/28/17

Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis

Phase: N/A Priority: Normal
NCT ID: NCT03052751 Org: User:
Start: 05/15/17 End: 08/06/18 Due: 08/06/19

An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

Phase: N/A Priority: Normal
NCT ID: NCT02326298 Org: User:
Start: 12/16/14 End: 10/24/18 Due: 10/24/19

A Study to Evaluate the Safety and Tolerability of Intravenous Brivaracetam (BRV) as Replacement for Oral Brivaracetam in Japanese Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

Phase: N/A Priority: Normal
NCT ID: NCT03685630 Org: User:
Start: 01/04/19 End: 03/27/21 Due: 03/27/22

A Clinical Study to Investigate the Long-term Use of Lacosamide as Monotherapy in Subjects Who Completed Study SP0994

Phase: N/A Priority: Normal
NCT ID: NCT02582866 Org: User:
Start: 01/31/16 End: 01/31/20 Due: 01/31/21

A Study to Evaluate Safety and Tolerability of Single Ascending Doses of Rozanolixizumab Administered by Subcutaneous Infusion in Healthy Japanese, Chinese and Caucasian Study Participants

Phase: N/A Priority: Normal
NCT ID: NCT03859219 Org: User:
Start: 03/18/19 End: 04/28/20 Due: 04/28/21

A Study to Test the Safety, Tolerability, and Pharmacokinetics of UCB0599 in Healthy Study Participants and Patients With Parkinson's Disease (PD)

Phase: N/A Priority: Normal
NCT ID: NCT04875962 Org: User:
Start: 05/06/19 End: 02/19/20 Due: 02/19/21

A Phase 2 Study of Radiprodil in Subjects With Drug-resistant Infantile Spasms (IS)

Phase: N/A Priority: Normal
NCT ID: NCT02829827 Org: User:
Start: 12/04/17 End: 10/02/18 Due: 10/02/19